- To be eligible patients must be currently receiving benefit in a Lilly study that has met its endpoints or has otherwise stopped.
- Patients must not be concurrently enrolled in any other type of medical research judged not to be scientifically or medically compatible with this study.
Nashville, Tennessee, 37203
Investigator: There may be multiple sites in this clinical trial. 1-877-CTLILLY (1-877-285-4559) or
There may be multiple sites in this clinical trial. 1-877-CTLILLY (1-877-285-4559) or
Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 9 AM - 5 PM Eastern time (UTC/GMT -5 hours, EST)
Eli Lilly and Company
Expanded Access program information for companies listed in the Expanded Access Company Directory is pulled daily from ClinicalTrials.gov, a resource provided by the National Institutes of Health in cooperation with the U.S. Food and Drug Administration. Click here for more information about ClinicalTrials.gov.